Suominen reports Q1 results on May 7. There’s a lot of room to improve from the low comparison figur...
Following the license agreement with Moderna in Q4’25, Nanexa continues to advance along three paral...
* '26e-'28e adj. EBITA down 24-13% * Webstep issues weigh significantly on revenue * Trading at NTM ...
Yesterday, Bittium published its Q1'26 business review.
While the Q1 report was rather undramatic, Xspray stands before potentially transformative months ah...
Redeye concludes that Q1 2026 was a clean beat for Litium across every line item.
Redeye provides a preview ahead of Fractal Gaming Group's Q1 2026 report due on 7 May.
Sleep Cycle’s Q1 2026 results confirms the transition toward a multi-product platform.
Redeye takes a more positive view of Hexatronic following an, in our view, solid Q1 report, which mo...
Taaleri's Q1 results were largely in line with our expectations on an underlying basis, owing specif...
We raise 2026E-28E adj. EPS by 9-15% after a solid Q1 and our fair value range to SEK 41-48 (39-45),...
* Defence order lifts Q1e sales to SEK 76m, +42% y-o-y * Entering the new year with stronger financi...
* Q1 surprised on gross margin: 45% vs. our 42% * Pricer transition a temporary drag, offset by Vusi...
* Strong profitability in weather-harsh Q1 * German roll-outs on track; we remain in upper end of gu...
* Q1 exceeded our expectations, but limited estimate revisions * Confirms that Q4 was likely the ser...
* Multi-year contracts of MSEK 300 announced in April * Lower product sales in Q1 * We adjust our fa...
* Q1 sales SEK 13m, adj. EBIT SEK -16m (vs. ABGSCe 8m & -12m) * Softer quarter; no machine deliverie...
Today, LIMES announced that its supervisory board has approved the FY25 annual accounts, confirming ...
Redeye retains its positive view of Addnode despite a relativley soft Q1 report.
* Q1 EBITDA of DKK -1.2m above ABG DKK -3.2m * FY'26 guidance unchanged * Expect mid-single-digit po...
